Emerging evidence in other solid tumor types such as melanoma and urothelial cancer show that T cell abundance correlates with a stroma-mediated source of immune resistance originating in transforming growth factor beta1 (TGFβ1)-responsive cancer-associated fibroblasts (CAFs). The gene discussed is TGFB1; the disease is melanoma.